Alejandro Dorenbaum

Insider Reports History

Location
San Diego, CA
Signature
/s/ Jennifer P. Lam, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alejandro Dorenbaum:

Company Role Class Num Shares Value Price $ Report Date Ownership
Reneo Pharmaceuticals, Inc. Chief Medical Officer Common Stock 30,000 $188,271 $6.28 12 Aug 2022 Direct
Reneo Pharmaceuticals, Inc. Chief Medical Officer Stock option (right to buy) 125,000 09 Dec 2022 Direct

Insider Reports Filed by Alejandro Dorenbaum

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OKUR Reneo Pharmaceuticals, Inc. 09 Dec 2022 2 $0 4 Chief Medical Officer 13 Dec 2022, 17:07
OKUR Reneo Pharmaceuticals, Inc. 10 Dec 2021 2 $0 4 Chief Medical Officer 14 Dec 2021, 15:30